 investigated DNA 29 unrelated pyruvate kinase (PK) deficiency (PKD) patients Central Europe hereditary nonspherocytic hemolytic anemia mutations PK-L/R gene. Among 58 potentially affected alleles, 53 mutations identified, 17 different other. 17 mutations, 13 single-nucleotide (nt) substitutions resulting amino acid exchanges, G787A (Gly263-Arg), G994A (Gly332-Ser), G1006T (Ala336-Ser), G1010A (Arg337-Gln), A1081G (Asn361-Asp), G1127T (Ser376-Ile), G1174A (Ala392-Thr), G1281T (Glu427-Asp), C1454T (Ser485-Phe), C1456T (Arg486-Trp), G1493A (Arg498-His), G1529A (Arg510-Gin), C1594T (Arg532-Trp); 1 in-frame triplet deletion, 1060delAAG (delLys354); 1 in-frame triplet insertion, 1203insAGC (insSer Cys401); 1 splicesite mutation, 101-1G-A; 1 frameshift deletion, 628delGT. Six mutations, 628delGT, G787A, G1010A, G1127T, G1281T, C1454T, described first time. test hypothesis single origin common PK mutation European population, G1529A, investigated patients four polymorphic sites PK-L/R gene: C/A nt 1705, C/T nt 1992, (ATT)n microsatellite intron J, polymorphism (T)10/(T)19 intron I. Nine patients homozygous mutation G1529A consistent four markers. group patients homozygous mutation G1529A, hematologic parameters clinical manifestations studied detail. Although identical mutation PK-L/R gene, patients affected differently. appearance ranges mild compensated hemolysis severe anemia. Possible molecular explanations discussed.